Immunoglobulin G has a role for systemic protein modulation in vivo: A new concept of protein homeostasis

被引:12
作者
Lee, Kyung-Yil [1 ]
Lee, Joon-Sung [1 ]
机构
[1] Catholic Univ, Coll Med, Dept Pediat, Seoul, South Korea
关键词
D O I
10.1016/j.mehy.2006.04.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The constant level of various proteins including albumin and cellular components in intravascular pool in vivo is strictly controlled by an unknown homeostatic mechanism, although there are fluctuations seen in pathologic conditions. Because the majority of the IgG in the serum is regarded as self-reactive natural autoantibodies, IgG may have a rote to react with all proteins in vivo. It is hypothesized that like an immune system, a homeostatic mechanism for the protein pool also has a sensitive rote to identify and memorize the extent and repertoire of both normal and pathogenic proteins on an individual basis, and IgG may be one of the major players in performing these functions. This hypothesis may explain the unresolved clinical observations as followed: (1) the marked increased IgG levels observed in self-limiting diseases presumed to come from immunological insults such as acute poststreptococcal glomerulonephritis and Kikuchi-Fujimoto disease, (2) an immediate reduction of all protein levels except immunoglobulins after intravenous immunoglobuln (IVIG) treatment in Kawasaki disease, (3) a unified explanation for the variety of immunomodulating effects exerted by IVIG, (4) the IgG-enzyme complexes observed in benign conditions such as macroamylasemia and hyperphosphatasemia, and (5) the marked decreased IgG level, which is correlated with the albumin level in minimal change nephrotic syndrome. IgG may be a 'watch-dog' for the disturbances of protein homeostasis in vivo. IgG may control the pathogenic proteins that appeared in disordered states, and it may help prevent the loss of proteins in case of nephrotic syndrome. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:848 / 855
页数:8
相关论文
共 59 条
[1]   PLASMA IGG POOL IS NOT DEFENDED FROM URINARY LOSS IN NEPHROTIC SYNDROME [J].
ALBANDER, HA ;
MARTIN, VI ;
KAYSEN, GA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :F333-F337
[2]   IMMUNOGLOBULIN-SYNTHESIS BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN MINIMAL CHANGE NEPHROTIC SYNDROME [J].
BEALE, MG ;
NASH, GS ;
BERTOVICH, MJ ;
MACDERMOTT, RP .
KIDNEY INTERNATIONAL, 1983, 23 (02) :380-386
[3]  
BEAMAN M, 1988, CLIN EXP IMMUNOL, V74, P425
[4]   MACROAMYLASEMIA - A NEWLY RECOGNIZED CAUSE FOR ELEVATED SERUM AMYLASE ACTIVITY [J].
BERK, JE ;
KIZU, H ;
WILDING, P ;
SEARCY, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 277 (18) :941-&
[5]   SODIUM DODECYL-SULFATE POLYACRYLAMIDE-GEL ELECTROPHORESIS PATTERNS OF PROTEINURIA IN VARIOUS RENAL DISEASES OF CHILDHOOD [J].
BROCKLEBANK, T ;
COOPER, EH ;
RICHMOND, K .
PEDIATRIC NEPHROLOGY, 1991, 5 (04) :371-375
[6]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[7]   Therapeutic plasma exchange: An update from the Canadian Apheresis Group [J].
Clark, WF ;
Rock, GA ;
Buskard, N ;
Shumak, KH ;
LeBlond, P ;
Anderson, D ;
Sutton, DM .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (06) :453-462
[8]  
CLARLTON B, 1985, J LAB CLIN MED, V105, P312
[9]   IMMEDIATE EFFECTS OF INTRAVENOUS IGG ADMINISTRATION ON PERIPHERAL-BLOOD B-CELLS AND T-CELLS AND POLYMORPHONUCLEAR CELLS IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
COOK, L ;
HOWARD, JF ;
FOLDS, JD .
JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (01) :23-31
[10]  
Dalakas MC, 1999, MUSCLE NERVE, V22, P1479, DOI 10.1002/(SICI)1097-4598(199911)22:11<1479::AID-MUS3>3.3.CO